HeyJaredJeffrey S. Smith
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 29, 2026
- Outlet visibility, for R Street Institute
- Top 5M sites
- Earliest in this view
- Jul 17, 2026
Latest articles
From Queue to Quality: Using AI to Modernize FDA Tobacco-Product Review - R Street Institute (opens the original)
Read excerpt
For general and media inquiries and to book our experts, please contact: pr@rstreet.org The U.S. Food and Drug Administration’s (FDA’s) Center for Tobacco Products (CTP) has a history of taking years to decide tobacco-product applications—decisions that determine which products may lawfully compete with combustible cigarettes and which reduced-risk claims manufacturers may make. The agency took nearly five years to decide the ZYN nicotine-pouch applications, nearly four years to authorize the Vu
Beyond the Leaf: A Risk-Based Framework for Kratom, 7-OH, and Synthetic Derivatives - R Street Institute (opens the original)
Read excerpt
For general and media inquiries and to book our experts, please contact: pr@rstreet.org Kratom policy is advancing quickly, but the science and the marketplace do not support treating all kratom-related products as one category. Botanical kratom, 7-hydroxymitragynine (7-OH) extracts/concentrates, and synthetic/semi-synthetic kratom-derived products differ in composition, route of administration, potency, likely risk, and appropriate regulatory response. These differences call for a tiered approa
Smokers Wanting to Quit Need Guidelines on How Vaping Can Help - R Street Institute (opens the original)
Read excerpt
A new paper in the Journal of the American Medical Association (JAMA) asks U.S. clinicians to address whether nicotine e-cigarettes can help adults stop smoking. The research recommends including e-cigarettes when discussing the risks and benefits of evidence-based cessation options with adults who smoke. Written by a harm reduction working group of the Society for Research on Nicotine and Tobacco (SRNT), it is a position paper, not a new federal guideline. However, it is still a dramatic change
R Street Comments on Placement of 7-OH on Schedule I - R Street Institute (opens the original)
Read excerpt
U.S. Department of Health and Human ServicesOffice of the Assistant Secretary for Health200 Independence Avenue SWWashington, DC 20201 Response to HHS-OASH-2026-0232: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I Submitted to the Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services My name is Dr. Jeffrey S. Smith, and I am a Resident Senior Fellow at the R Street Institute, a nonprofit, nonpartisan public policy resear
Ending the Cigarette Century: What Sweden, Japan, and New Zealand Reveal About Accelerating the Global End of Smoking - R Street Institute (opens the original)
Read excerpt
For general and media inquiries and to book our experts, please contact: pr@rstreet.org Tobacco remains the leading preventable cause of premature death worldwide, and although global smoking prevalence has declined under the World Health Organization Framework Convention on Tobacco Control, the pace of progress remains too slow to prevent hundreds of millions of additional smoking-attributable deaths this century. Conventional tobacco-control measures—taxation, smoke-free laws, advertising rest
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For R Street Institute, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.